EXHIBIT 10.1

Exhibit 10.1

NOVELIS APPOINTS NEW INDEPENDENT DIRECTOR TO BOARD

ATLANTA, June 30 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE: NVL) (TSX: NVL)
today announced that it has appointed a new independent director, Edward A.
Blechschmidt, to its Board of Directors. Mr. Blechschmidt retired in 2002 as
Chairman and Chief Executive Officer of Gentiva Health Services, Inc., a leading
provider of specialty pharmaceutical and home health care services that was spun
off from Olsten Corporation and taken public. He remained a director until May
2005.

This appointment takes effect immediately and continues until Novelis' 2006
annual meeting, when Mr. Blechschmidt will be nominated for election to serve in
the coming year. The annual meeting has been delayed and will take place by the
end of 2006.

William T. Monahan, Chairman of the Board, said, "We are very pleased to welcome
Ed Blechschmidt to Novelis' Board of Directors. Ed's strong financial
background, operating experience and spin-related expertise, combined with his
focus on generating shareholder value, will make him a valuable addition to our
Board as Novelis becomes a world-class organization."

Mr. Blechschmidt fills the second of two vacancies that resulted from the
previously announced increase in the maximum size of Novelis' Board from 12 to
14 members. The first vacancy was filled by Kevin M. Twomey, who was appointed
to the Board in May.

Before joining Gentiva in 2000, Mr. Blechschmidt, 53, served as Chief Executive
Officer and a director of Olsten Corporation, the conglomerate from which
Gentiva Health Services was spun off. He served as President of Olsten from
October 1998 to March 1999. He also served as President and Chief Executive
Officer of Siemens Nixdorf Americas and Siemens Pyramid Technologies from July
1996 to October 1998. Prior to that, he spent more than 20 years with Unisys
Corporation, where he held positions of increasing responsibility in finance,
administration and operations, including Chief Financial Officer.

Mr. Blechschmidt serves as a director of HealthSouth Corp., having joined the
Board in 2004, Lionbridge Technologies, Inc., Option Care, Inc., and Columbia
Laboratories, Inc. He serves as Chair of the Audit Committees of the Boards of
HealthSouth and Lionbridge Technologies.

Mr. Blechschmidt earned his bachelor's degree in business from Arizona State
University.

Novelis is the global leader in aluminum rolled products and aluminum can
recycling. The company operates in 11 countries and has approximately 13,000
employees. Novelis has the unrivaled capability to provide its customers with a
regional supply of technologically sophisticated rolled aluminum products
throughout Asia, Europe, North America and South America. Through its advanced
production capabilities, the company supplies aluminum sheet and foil to the
automotive and transportation, beverage and food packaging, construction and
industrial, and printing markets. For more information, visit
http://www.novelis.com.



Statements made in this news release which describe Novelis' intentions,
expectations or predictions may be forward-looking statements within the meaning
of securities laws. Examples of forward-looking statements in this news release
include, among other matters, Novelis' ability to execute on its business
strategy, hold an annual meeting by the end of 2006, and that Mr. Blechschmidt
will be nominated for election at such meeting. Novelis cautions that, by their
nature, forward-looking statements involve risk and uncertainty, that the annual
meeting could be further delayed in the event Novelis has not issued its annual
report on Form 10-K for the fiscal year ended 2005 by the end of 2006, and that
Mr. Blechschmidt has not yet been nominated for election at the 2006 annual
meeting. We do not intend, and we disclaim any obligation, to update any
forward-looking statements, whether as a result of new information, future
events or otherwise. Please refer to important risk factors listed under the
caption "Special Note Regarding Forward-Looking Statements and Market Data" in
our quarterly report on Form 10-Q for the period ended September 30, 2005, as
filed with the SEC. The risk factors included in our quarterly report on Form
10-Q for the period ended September 30, 2005, are specifically incorporated by
reference into this news release.


SOURCE Novelis Inc.
-0- 06/30/2006
/CONTACT: Media: Charles Belbin, +1-404-814-4260,
charles.belbin@novelis.com, or Investors: Holly K. Ash, +1-404-814-4212,
holly.ash@novelis.com, both of Novelis/
/Web site: http://www.novelis.com /
(NVL NVL.)